Guide for Pharmaceutical Manufacturing Industry Research & Development Medical Pharmacy Students FDA updates Guidelines
Custom Search

Friday, February 5, 2010

Requirements of Building and Facilities for Sterile Dosage form , Injectables

Following are some key abstract points form FDA'S guidance for sterile dosage form manufacturing this has listed follwing guidlines for Building and facilities for Sterile Dosage form .



21 CFR 211.42(b) states, in part, that “The flow of components, drug product containers, closures, labeling, in-process materials, and drug products through the building or buildings shall be designed to prevent contamination.”

 21 CFR 211.42(c) states, in part, that “Operations shall be performed within specifically defined areas of adequate size. There shall be separate or defined areas or such other control systems for the firm’s operations as are necessary to prevent contamination or mixups during the course of the following procedures: * * * (10) Aseptic processing, which includes as appropriate: (i) Floors, walls, and ceilings of smooth, hard surfaces that are easily cleanable; (ii) Temperature and humidity controls; (iii) An air supply filtered through high-efficiency particulate air filters under positive pressure, regardless of whether flow is laminar or nonlaminar; (iv) A system for monitoring environmental conditions; (v) A system for cleaning and disinfecting the room and equipment to produce aseptic conditions; (vi) A system for maintaining any equipment used to control the aseptic conditions.”

21 CFR 211.46(b) states that “Equipment for adequate control over air pressure, micro-organisms, dust, humidity, and temperature shall be provided when appropriate for the manufacture, processing, packing, or holding of a drug product.”

 21 CFR 211.46(c) states, in part, that “Air filtration systems, including prefilters and particulate matter air filters, shall be used when appropriate on air supplies to production areas * * *.” 21 CFR 211.63 states that “Equipment used in the manufacture, processing, packing, or holding of a drug product shall be of appropriate design, adequate size, and suitably located to facilitate operations for its intended use and for its cleaning and maintenance.”

21 CFR 211.65(a) states that “Equipment shall be constructed so that surfaces that contact components, in-process materials, or drug products shall not be reactive, additive, or absorptive so as to alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.”

21 CFR 211.67(a) states that “Equipment and utensils shall be cleaned, maintained, and sanitized at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.”

 21 CFR 211.113(b) states that “Appropriate written procedures, designed to prevent microbiological contamination of drug products purporting to be sterile, shall be established and followed. Such procedures shall include validation of any sterilization process.”

Separete arias for aseptic process , like filling and other critical activity should be controlled to get required degree of air quality depending up on nature of operation.

Clean Aira Parameters should be monitored and supported by practicle data obtained in qualification studies.

Initial cleanroom qualification includes, in part, an assessment of air quality under as-built, static conditions. It is important for area qualification and classification to place most emphasis on data generated under dynamic conditions (i.e., with personnel present, equipment in place, and operations ongoing). An adequate aseptic processing facility monitoring program also will assess conformance with specified clean area classifications under dynamic conditions on a routine basis.

Class 100 Aria and class 10000 Aira

Two clean areas are very importance for sterile drug product quality:
1.Critical area Class 100
2. supporting clean areas associated with critial aria.(class 10000 )

In next post we will provide in details about classification of clean rooms , or Airias.

We encourage you to signe up with this website ,so that you will get articles delivered in to your email inbox as and when this website is updated., our authers write on many topics about pharmaceutical dosage form manufacturing , good manufacturing practices in pharmaceuticals gmp guidelines , Pharmaceutical Validations , Pharmaceutical Quality Assurance , there is complete information about pharmaceuticals ,
This website is reffered by industry personals as well as teachers and students of all level.

This website is most favorite Amongst professionals almost all pharmaceutical companies in USA , Pharmaceutical companies in UK , Pharmaceutical companies in Japan , Canada , UAE , Pharmaceutical companies in India .This website is pharmaceutical manufacturers guide .

No comments:

Pharmaceutical Educational Website Autored by B V WAGHMARE

Pharmaceutical Educational Website Autored by B V WAGHMARE

Like This Website on Facebook and Stay Connected Share This Article with your Friends




Latest Pharma Update

USFDA approves first drug Inmazeb to treat Ebola Virus Infection

US FDA approved first drug to treat Ebola Virus Infection (zaire ebolavirus) . So far there was no drug treatment available for Ebola virus ...

You May Also Like

If you are looking for latest Pharmaceutical Manufacturing Guidelines of USFDA, UKMHRA, TGA WHO GMP then this website is one of most popular source.
Subscribe to this website by providing your email


Enter your email address get latest Pharma Guideline and technology update by email whenever this website is updated